China-US Economic Ties

Fentanyl Chemicals Don’t Come From China, Beijing Tells US

 

Beijing diplomats have denied US claims that the chemicals used by Mexican drug cartels to make the deadly opioid fentanyl come from China.

China’s Mexico embassy said in a statement on Tuesday that Beijing had measures in place to prevent the trafficking of substances used to make illegal drugs, and said the US was “blindly shirking its responsibilities” by not taking domestic action.

“The root of the fentanyl crisis in the United States is within itself,” the embassy said.

US President Joe Biden’s administration has been seeking cooperation with both Mexico and China in stemming the flow of fentanyl, which has fuelled a health crisis and a sharp rise in overdose deaths, as well as its precursor chemicals.

The US Drug Enforcement Administration says the addictive painkiller and its precursors are transported from China to Mexico, the US and Canada, often by international mail.

 

Also on AF: China’s Feuding Online Fashion Retailers: Temu vs Shein

 

China had denied the illegal trafficking of fentanyl to Mexico in an April statement, though it did not address precursor chemicals.

The embassy on Tuesday said China was “actively coordinating and strengthening” supervision of drug-making substances with Mexico.

The US embassy in Mexico and Mexico’s foreign ministry did not immediately respond to requests for comment.

The Chinese statement, the embassy said, comes after recent comments from US Ambassador to Mexico Ken Salazar and other US officials.

Last week, the US Treasury sanctioned 10 people with suspected ties to the Sinaloa Cartel’s fentanyl network, as well as a company accused of importing chemicals from China.

“This represents a blow to [the cartel’s] financial operations and illicit activities, since the company receives chemical shipments from China,” Salazar said in a statement.

 

  • Reuters with additional editing by Sean O’Meara

 

Read more:

China Chemical Firms Hit With First-Ever US Fentanyl Charges

China’s Xi Puts a Positive Spin on Talks With Blinken

Beijing Slams US Sanctions On Chinese Drug-Making Firms

 

 

Sean O'Meara

Sean O'Meara is an Editor at Asia Financial. He has been a newspaper man for more than 30 years, working at local, regional and national titles in the UK as a writer, sub-editor, page designer and print editor. A football, cricket and rugby fan, he has a particular interest in sports finance.

Recent Posts

Bitcoin Comeback Sees Market Worth $1 Trillion Again

The globe’s biggest crypto coin has soared 22% in value this year after the US…

10 hours ago

China’s Free Trade Olive Branch to EU Amid Subsidy Probes

Beijing’s Foreign Minister Wang Yi said the EU and China could avoid confrontation through cooperation

11 hours ago

Curbs on ASML ‘to Stop Use of Advanced Chips by China Military’

ASML tools are used to make advanced semiconductors that can go into "high-value weapons systems…

13 hours ago

Chinese Rocket Failure Opened Door for SpaceX in Indonesia

The failure of a Chinese rocket launch in April 2020 gave Elon Musk's SpaceX the…

13 hours ago

Fake Chinese Accounts Flourish on X, Analysis Shows – WaPo

Researchers say Chinese propaganda "has increasingly sought to stoke existing US divisions in the same…

14 hours ago

Hang Seng Lifted by Rate Cut, Nikkei Dips on Tech Worries

China’s markets were slow to react to its biggest ever mortgage rate cut while Tokyo’s…

15 hours ago